Evaluation of the potential of the phytocannabinoids, cannabidivarin (CBDV) and Δ9-tetrahydrocannabivarin (THCV), to produce CB1receptor inverse agonism symptoms of nausea in rats
出版年份 2013 全文链接
标题
Evaluation of the potential of the phytocannabinoids, cannabidivarin (CBDV) and Δ9-tetrahydrocannabivarin (THCV), to produce CB1receptor inverse agonism symptoms of nausea in rats
作者
关键词
-
出版物
BRITISH JOURNAL OF PHARMACOLOGY
Volume 170, Issue 3, Pages 671-678
出版商
Wiley
发表日期
2013-08-14
DOI
10.1111/bph.12322
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Effect of low doses of cannabidiolic acid and ondansetron on LiCl-induced conditioned gaping (a model of nausea-induced behaviour) in rats
- (2013) EM Rock et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabidivarin is anticonvulsant in mouse and rat
- (2012) AJ Hill et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabidiolic acid prevents vomiting inSuncus murinusand nausea-induced behaviour in rats by enhancing 5-HT1Areceptor activation
- (2012) D Bolognini et al. BRITISH JOURNAL OF PHARMACOLOGY
- Effect of chronic exposure to rimonabant and phytocannabinoids on anxiety-like behavior and saccharin palatability
- (2012) Lesley D. O'Brien et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Cannabinoid actions at TRPV channels: effects on TRPV3 and TRPV4 and their potential relevance to gastrointestinal inflammation
- (2011) L. De Petrocellis et al. Acta Physiologica
- Symptom-relieving and neuroprotective effects of the phytocannabinoid Δ9-THCV in animal models of Parkinson's disease
- (2011) C García et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabidiol, a non-psychotropic component of cannabis, attenuates vomiting and nausea-like behaviour via indirect agonism of 5-HT1A somatodendritic autoreceptors in the dorsal raphe nucleus
- (2011) EM Rock et al. BRITISH JOURNAL OF PHARMACOLOGY
- Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), Δ9-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive–compulsive behaviour
- (2011) Serena Deiana et al. PSYCHOPHARMACOLOGY
- The plant cannabinoid Δ9-tetrahydrocannabivarin can decrease signs of inflammation and inflammatory pain in mice
- (2010) Daniele Bolognini et al. BRITISH JOURNAL OF PHARMACOLOGY
- Guidelines for reporting experiments involving animals: the ARRIVE guidelines
- (2010) JC McGrath et al. BRITISH JOURNAL OF PHARMACOLOGY
- Inverse agonism of cannabinoid CB1 receptors potentiates LiCl-induced nausea in the conditioned gaping model in rats
- (2010) CL Limebeer et al. BRITISH JOURNAL OF PHARMACOLOGY
- A novel peripherally restricted cannabinoid receptor antagonist, AM6545, reduces food intake and body weight, but does not cause malaise, in rodents
- (2010) NL Cluny et al. BRITISH JOURNAL OF PHARMACOLOGY
- Animal research: Reporting in vivo experiments: The ARRIVE guidelines
- (2010) Carol Kilkenny et al. BRITISH JOURNAL OF PHARMACOLOGY
- Effects of cannabinoids and cannabinoid-enrichedCannabisextracts on TRP channels and endocannabinoid metabolic enzymes
- (2010) Luciano De Petrocellis et al. BRITISH JOURNAL OF PHARMACOLOGY
- Δ9-Tetrahydrocannabivarin suppresses in vitro epileptiform and in vivo seizure activity in adult rats
- (2010) Andrew J. Hill et al. EPILEPSIA
- Comparative topical anti-inflammatory activity of cannabinoids and cannabivarins
- (2010) Aurelia Tubaro et al. FITOTERAPIA
- Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity
- (2010) Joseph Tam et al. JOURNAL OF CLINICAL INVESTIGATION
- Depression-like phenotype following chronic CB1 receptor antagonism
- (2010) Chad E. Beyer et al. NEUROBIOLOGY OF DISEASE
- Synthetic and plant-derived cannabinoid receptor antagonists show hypophagic properties in fasted and non-fasted mice
- (2009) Gernot Riedel et al. BRITISH JOURNAL OF PHARMACOLOGY
- Pleiotropic Effects of Rimonabant: Clinical Implications
- (2009) Jean-Pierre Despres CURRENT PHARMACEUTICAL DESIGN
- Potential anxiogenic effects of cannabinoid CB1 receptor antagonists/inverse agonists in rats: Comparisons between AM4113, AM251, and the benzodiazepine inverse agonist FG-7142
- (2009) K.S. Sink et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Melancholic features related to rimonabant
- (2009) Bernardo de Mattos Viana et al. GENERAL HOSPITAL PSYCHIATRY
- Antidepressant-like effects of paroxetine are produced by lower doses than those which produce nausea
- (2009) Katharine J. Tuerke et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Potential of the rat model of conditioned gaping to detect nausea produced by rolipram, a phosphodiesterase-4 (PDE4) inhibitor
- (2008) Erin M. Rock et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Oral bioavailability of the novel cannabinoid CB1 antagonist AM6527: Effects on food-reinforced behavior and comparisons with AM4113
- (2008) K.S. Sink et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Effect of 5-HT3 antagonists and a 5-HT1A agonist on fluoxetine-induced conditioned gaping reactions in rats
- (2008) Cheryl L. Limebeer et al. PSYCHOPHARMACOLOGY
- The psychoactive plant cannabinoid, Δ9-tetrahydrocannabinol, is antagonized by Δ8- and Δ9-tetrahydrocannabivarin in mice in vivo
- (2007) R G Pertwee et al. BRITISH JOURNAL OF PHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started